Isa Odidi
Vorstandsvorsitzender bei INTELLIPHARMACEUTICS INTERNATIONAL INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Isa Odidi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INTELLIPHARMACEUTICS INTERNATIONAL INC. | Vorsitzender | - | - |
| Vorstandsvorsitzender | 01.01.1998 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 | - | |
| Gründer | 01.01.1998 | - | |
| Direktor/Vorstandsmitglied | 01.09.2004 | - | |
| Toronto Institute of Pharmaceutical Technology | Corporate Officer/Principal | - | - |
| Smart Pharmaceutical Shanghai Ltd. | Vorsitzender | - | - |
Karriereverlauf von Isa Odidi
Ehemalige bekannte Positionen von Isa Odidi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
IntelliPharmaCeutics Ltd.
 IntelliPharmaCeutics Ltd. Pharmaceuticals: MajorHealth Technology IntelliPharmaCeutics Ltd. designs and develops controlled release drugs. The firm engages in research, development, licensing & marketing of new and generic controlled release pharmaceutical products. It provides life cycle management or new chemical entity delivery system solutions for small molecule drugs through its patented HYPERMATRIX technology. It was founded in 1998 and is headquartered in Toronto, Canada. | Präsident | - | 27.10.2009 |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01.01.1995 | 01.01.1998 |
Ausbildung von Isa Odidi
| University of London | Doctorate Degree |
| Rotman School of Management | Masters Business Admin |
| Ahmadu Bello University | Undergraduate Degree |
Statistik
International
| Kanada | 6 |
| Vereinigtes Königreich | 2 |
| Nigeria | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chairman | 2 |
| President | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTELLIPHARMACEUTICS INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
IntelliPharmaCeutics Ltd.
IntelliPharmaCeutics Ltd. Pharmaceuticals: MajorHealth Technology IntelliPharmaCeutics Ltd. designs and develops controlled release drugs. The firm engages in research, development, licensing & marketing of new and generic controlled release pharmaceutical products. It provides life cycle management or new chemical entity delivery system solutions for small molecule drugs through its patented HYPERMATRIX technology. It was founded in 1998 and is headquartered in Toronto, Canada. | Health Technology |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
| Smart Pharmaceutical Shanghai Ltd. |
